Effect of Allopurinol in treatment of patients with Non ST-segment elevation myocardial infarctio
Phase 3
- Conditions
- Acute myocardial infarction without ST segment elevation.Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20191223045866N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Ischemic type chest pain
Non ST-segment elevation
Positive troponin biomarker
Age of patient between 18-85
Exclusion Criteria
History of Allopurinol consumption
Cardiogenic shock
Pulmonary edema with functional class III orIV
Ventricular tachycardia or ventricular fibrillation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory markers including highly sensitive C-reactive protein and highly sensitive cardiac troponin. Timepoint: Before the angiography and within 24 hours after acute myocardial infarction. Method of measurement: Blood sampling and laboratory assessment.
- Secondary Outcome Measures
Name Time Method